Standout Papers

2016 Revisions to the 2010/2011 f... 1998 2026 2007 2016 2.0k
  1. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria (2016)
    Frederick Wolfe, Daniel J. Clauw et al. Seminars in Arthritis and Rheumatism
  2. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States (1998)
    Reva C. Lawrence, Charles G. Helmick et al. Arthritis & Rheumatism

Citation Impact

Citing Papers

Exercise for treating fibromyalgia syndrome
2007
Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century
2015 StandoutNobel
Rheumatoid Factor as a Potentiator of Anti–Citrullinated Protein Antibody–Mediated Inflammation in Rheumatoid Arthritis
2014
Measuring the Global Burden of Disease
2013 Standout
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
The personal and national costs of lost labour force participation due to arthritis: an economic study
2013
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
The economics of treatment in early rheumatoid arthritis
2009
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
2001 Standout
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Fibromyalgia and Overlapping Disorders: The Unifying Concept of Central Sensitivity Syndromes
2007
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
2005 Standout
Changes Over Time in the Diagnosis of Rheumatoid Arthritis in a 10-year Cohort
2009
Rheumatoid arthritis
2016 Standout
Myogenous Temporomandibular Disorders: Diagnostic and Management Considerations
2007
Interrater reliability in myofascial trigger point examination
1997 Standout
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
2009
Defining remission in rheumatoid arthritis: Results of an initial american college of rheumatology/european league against rheumatism consensus conference
2009
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
The Failing Heart — An Engine Out of Fuel
2007 Standout
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
2005
The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: A longitudinal analysis
2004
The Symptoms of Osteoarthritis and the Genesis of Pain
2008
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Psychosocial and behavioral assessment of patients with temporomandibular disorders: Diagnostic and treatment implications
1997
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Patient-Driven Outcomes in Rheumatoid Arthritis
2009
Dendritic cells: versatile controllers of the immune system
2007 StandoutNobel
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Management of Fibromyalgia Syndrome
2004
Uric Acid and Cardiovascular Risk
2008 Standout
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
2006
Pattern Recognition Receptors and Inflammation
2010 Standout
The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
1993 Standout
Intensive Weight Loss Program Improves Physical Function in Older Obese Adults with Knee Osteoarthritis
2006
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Treatment of Fibromyalgia Syndrome With Antidepressants
2009
Severe Sepsis and Septic Shock
2013 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
The impact of a meditation-based stress reduction program on fibromyalgia
1993
Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks
2006
Modelling the cost effectiveness of TNF-  antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry
2007
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Differences in unpleasantness induced by experimental pressure pain between patients with fibromyalgia and healthy controls
2004
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
Antidepressants and Cognitive-Behavioral Therapy for Symptom Syndromes
2006
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
2006
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
2008
The mortality of rheumatoid arthritis
1994
Graves' Ophthalmopathy
2010 Standout
Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications
1996
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
The Role of Knee Alignment in Disease Progression and Functional Decline in Knee Osteoarthritis
2001 Standout
RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories
2008
Sustained improvement produced by nonpharmacologic intervention in fibromyalgia: Results of a pilot study
2000
The prevalence and characteristics of fibromyalgia in the general population
1995 Standout
Macrophage migration inhibitory factor: a regulator of innate immunity
2003 Standout
Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate
2002
Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression
1998
Systemic Lupus Erythematosus
2011 Standout
The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review
2011 Standout
The occurrence and inter-rater reliability of myofascial trigger points in the quadratus lumborum and gluteus medius: A prospective study in non-specific low back pain patients and controls in general practice
1994
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled trial
2007
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 Standout
Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: The arthritis, diet, and activity promotion trial
2004
Cyclooxygenase-2???Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients
2001
Genetic predisposition to respiratory infection and sepsis
2011
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
2005
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Heart failure
2005
Rheumatoid arthritis
2010 Standout
Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis
2008
Special article the economic cost and social and psychological impact of musculoskeletal conditions
1995
The Inflammasomes
2010 Standout
Mechanisms and Functions of Inflammasomes
2014 Standout
Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study
2012
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS)
2009
A Randomized Trial of Tai Chi for Fibromyalgia
2010 Standout
Cancer-related inflammation
2008 StandoutNature
Osteoarthritis
2019 Standout
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
2008
Sugar‐sweetened soft drinks, diet soft drinks, and serum uric acid level: The third national health and nutrition examination survey
2007
Presence of comorbidities and prognosis of clinical symptoms in knee and/or hip osteoarthritis: A systematic review and meta-analysis
2017
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
2007
Functional somatic syndromes: one or many?
1999
OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence
2007
The individual and socioeconomic impact of osteoarthritis
2014
Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one‐year double‐blind study in 174 patients
2002
Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions
2005
The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
2014
The course of established rheumatoid arthritis
2007
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
2008
Comorbidities in rheumatoid arthritis
2007
The Simplified Disease Activity Index and Clinical Disease Activity Index to Monitor Patients in Standard Clinical Care
2009
Treatment of fibromyalgia with antidepressants
2000
Methotrexate in Rheumatoid Arthritis
1987
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents
2009
Exercise for fibromyalgia: a systematic review.
2008
MIF Signal Transduction Initiated by Binding to CD74
2003 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Exercise for osteoarthritis of the hip
2014
Overview of benefit/risk of biological agents.
2005
A review of the current use of rituximab in autoimmune diseases
2008
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis
2003
Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs
2014
Temporomandibular Disorders
2008 Standout
Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials
2015
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
2013
Incidence of Giant Cell Arteritis and Characteristics of Patients: Data‐Driven Analysis of Comorbidities
2014
Mortality in rheumatoid arthritis: 2008 update.
2009
Acupuncture for peripheral joint osteoarthritis
2010
Gender differences in prevalence of upper extremity musculoskeletal disorders
2004
Fibromyalgia Syndrome and Myofascial Pain Syndrome
1995
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis
2012
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Chronic conditions and the decline in late-life disability
2007
Education, self‐care, and outcomes of rheumatic diseases: Further challenges to the “biomedical model” paradigm
1997

Works of Frederick Wolfe being referenced

Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group.
2001
The prevalence and meaning of fatigue in rheumatic disease
1996
Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes.
2007
A reappraisal of HAQ disability in rheumatoid arthritis
2000
Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti–tumor necrosis factor therapy
2004
The Disease Activity Score is not suitable as the sole criterion for initiation and evaluation of anti–tumor necrosis factor therapy in the clinic: Discordance between assessment measures and limitations in questionnaire use for regulatory purposes
2005
Resistance of rheumatoid arthritis patients to changing therapy: Discordance between disease activity and patients' treatment choices
2007
Back pain in osteoarthritis of the knee
1996
The latex test revisited. Rheumatoid factor testing in 8,287 rheumatic disease patients
1991
Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders
2006
Toward a multidimensional health assessment questionnaire (MDHAQ): Assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format
1999
Listening to the patient: A practical guide to self-report questionnaires in clinical care
1999
The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic
1997
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
1998 Standout
A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia
1997
Methotrexate in rheumatoid arthritis. a five‐year prospective multicenter study
1994
Direct medical costs and their predictors in patients with rheumatoid arthritis
2003
The epidemiology of drug treatment failure in rheumatoid arthritis
1995
A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis
2002
Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms.
1995
Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
2002
The relationship between fibromyalgia and temporomandibular disorders: prevalence and symptom severity.
1996
The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course of the illness.
2001
Work and disability status of persons with fibromyalgia.
1997
Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activity
2008
Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis.
2005
Household income and earnings losses among 6,396 persons with rheumatoid arthritis.
2005
The epidemiology of tender points: a prospective study of 1520 patients.
1985
The Fibromyalgia and Myofascial Pain Syndromes
1991
Elevated MMPI scores for hypochondriasis, depression, and hysteria in patients with rheumatoid arthritis reflect disease rather than psychological status
1986
Fibrositis (Fibromyalgia) in rheumatoid arthritis.
1984
Functional ability and work status in patients with fibromyalgia
1988
Fibromyalgia: The Clinical Syndrome
1989
The problem of rheumatoid arthritis disease activity and remission in clinical practice.
2008
The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease.
1992
A brief introduction to the National Data Bank for Rheumatic Diseases.
2006
Fibromyalgia
1990
A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II).
2005
The Epidemilogy of Fibromyalgia
1993
Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients.
2004
Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1,522 patients.
1991
Rankless by CCL
2026